Literature DB >> 15558997

Central nervous system decompression sickness and venous gas emboli in hypobaric conditions.

Ulf I Balldin1, Andrew A Pilmanis, James T Webb.   

Abstract

INTRODUCTION: Altitude decompression sickness (DCS) that involves the central nervous system (CNS) is a rare but potentially serious condition. Identification of early symptoms and signs of this condition might improve treatment.
METHODS: We studied data from 26 protocols carried out in our laboratory over the period 1983-2003; all were designed to provoke DCS in a substantial proportion of subjects. The data set included 2843 cases. We classified subject-exposures that resulted in DCS as: 1) neurological DCS of peripheral and/or central origin (NEURO); 2) a subset of those that involved only the CNS (CNS); and 3) all other cases, i.e., DCS cases that did not have a neurological component (OTHER). For each case, echo imaging data were used to document whether venous gas emboli (VGE) were present, and their level was classified as: 1) any level, i.e., Grade 1 or higher (VGE-1); and 2) high level, Grade 4 (VGE-4).
RESULTS: There were 1108 cases of altitude DCS in the database; 218 were classified as NEURO and 49 of those as CNS. VGE-1 were recorded in 83.8% of OTHER compared with 58.7% of NEURO and 55.1% of CNS (both p < 0.001 compared with OTHER). The corresponding values for VGE-4 were 48.8%, 37.0%, and 34.7% (p < 0.001, compared to OTHER). Hyperbaric oxygen (HBO) was used to treat about half of the CNS cases, while all other cases were treated with 2 h breathing 100% oxygen at ground level. DISCUSSION: Since only about half of the rare cases of hypobaric CNS DCS cases were accompanied by any level of VGE, echo imaging for bubbles may have limited application for use as a predictor of such cases.

Entities:  

Keywords:  NASA Discipline Environmental Health; Non-NASA Center

Mesh:

Year:  2004        PMID: 15558997

Source DB:  PubMed          Journal:  Aviat Space Environ Med        ISSN: 0095-6562


  7 in total

1.  Utilization of MRI for Cerebral White Matter Injury in a Hypobaric Swine Model-Validation of Technique.

Authors:  Jennifer A McGuire; Paul M Sherman; Erica Dean; Jeremy M Bernot; Laura M Rowland; Stephen A McGuire; Peter V Kochunov
Journal:  Mil Med       Date:  2017-05       Impact factor: 1.437

2.  White matter and hypoxic hypobaria in humans.

Authors:  Stephen A McGuire; Meghann C Ryan; Paul M Sherman; John H Sladky; Laura M Rowland; S Andrea Wijtenburg; L Elliot Hong; Peter V Kochunov
Journal:  Hum Brain Mapp       Date:  2019-03-29       Impact factor: 5.038

3.  Lower neurocognitive function in U-2 pilots: Relationship to white matter hyperintensities.

Authors:  Stephen A McGuire; David F Tate; Joe Wood; John H Sladky; Kent McDonald; Paul M Sherman; Elaine S Kawano; Laura M Rowland; Beenish Patel; Susan N Wright; Elliot Hong; Jennifer Rasmussen; Adam M Willis; Peter V Kochunov
Journal:  Neurology       Date:  2014-07-09       Impact factor: 9.910

4.  White Matter Integrity in High-Altitude Pilots Exposed to Hypobaria.

Authors:  Stephen A McGuire; Goldie R E Boone; Paul M Sherman; David F Tate; Joe D Wood; Beenish Patel; George Eskandar; S Andrea Wijtenburg; Laura M Rowland; Geoffrey D Clarke; Patrick M Grogan; John H Sladky; Peter V Kochunov
Journal:  Aerosp Med Hum Perform       Date:  2016-12-01       Impact factor: 1.053

5.  High altitude is associated with pTau deposition, neuroinflammation, and myelin loss.

Authors:  Diego Iacono; Erin K Murphy; Paul M Sherman; Holly Chapapas; Bianca Cerqueira; Christine Christensen; Daniel P Perl; John Sladky
Journal:  Sci Rep       Date:  2022-04-27       Impact factor: 4.996

6.  Hyperintense white matter lesions in 50 high-altitude pilots with neurologic decompression sickness.

Authors:  Stephen A McGuire; Paul M Sherman; Anthony C Brown; Andrew Y Robinson; David F Tate; Peter T Fox; Peter V Kochunov
Journal:  Aviat Space Environ Med       Date:  2012-12

7.  White matter hyperintensities on MRI in high-altitude U-2 pilots.

Authors:  Stephen McGuire; Paul Sherman; Leonardo Profenna; Patrick Grogan; John Sladky; Anthony Brown; Andrew Robinson; Laura Rowland; Elliot Hong; Beenish Patel; David Tate; Elaine S Kawano; Peter Fox; Peter Kochunov
Journal:  Neurology       Date:  2013-08-20       Impact factor: 9.910

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.